华东医药：2025年半年度报告

2025Semi-annualReport August20,2025 SectionIImportantNotes,TableofContentsandDefinitions TheBoardofDirectors,directors,andseniormanagementofHuadongMedicineCo.,Ltd.(hereinafter referred to as the"Company")herebyguaranteethattheinformationpresentedinthisreportisauthentic,accurateandcomplete,andfreeoffalserecords,misleadingstatementsormaterialomissions,andshallundertakeindividualandjointlegalliabilities. LvLiang,theCompany’slegalrepresentativeandtheofficerinchargeofaccounting,andQiuRenbo,headoftheaccountingdepartment(accountingmanager)hereby declare that the financial statements in this semi-annualreportareauthentic,accurate,andcomplete. AlldirectorshaveattendedtheBoardofDirectorsmeetingtoreviewthissemi-annualreport. Thefuture plans,development strategies and other forward-lookingstatementsinthissemi-annualreportshallnotbeconsideredasasubstantialcommitmentoftheCompanytoinvestors.Investorsandrelatedpartiesshouldbefullyawareoftherisks,andunderstandthedifferencesbetweenplans,forecastsandcommitments. TheriskstheCompanyfacesinoperationincludeindustrypolicyandproductpricereductionrisk,newdrugR&Drisk,investmentandM&Ariskandexchangeratefluctuationrisk.Fordetails,pleasereferto"X.Risksfacedbythe Company and countermeasures"in"Section III.Management'sDiscussionandAnalysis".Therefore,investorsarekindlyremindedtopayattentiontopossibleinvestmentrisks. ThedividenddistributionschemeapprovedatthemeetingoftheBoardofDirectorsisasfollows:Onthebasisof1,754,021,048.00shares—derivedbyexcluding56,000.00 restricted stock(pending repurchase and cancellation)fromtheexistingtotalsharecapitalof1,754,077,048.00shares,RMB 3.50(beforetax)of cash dividends per ten shares will be distributed to allshareholders;atotalof0bonusshares(beforetax)willbeissued;andnocapitalreserve will be converted to increase the capital stock.This 2025interimprofitdistributionschemefallswithinthescopeauthorizedbythe2024AnnualShareholders'MeetingresolutiontotheBoardofDirectorsanddoesnotrequirefurtherapprovalbytheShareholders'Meeting. Accordingto“StockListingRulesoftheShenzhenStockExchange”,iflistedcompanieshavebothChineseandotherlanguageversionofpublicnotice,theyshouldensurethecontentofbothversionsarethesame.Inthecaseofdiscrepancy,theoriginalversioninChineseshallprevail. TableofContents SectionIImportantNotes,TableofContentsandDefinitions..............................................................................2SectionIICompanyProfileandKeyFinancialIndicators..................................................................................11SectionIIIManagement'sDiscussionandAnalysis..............................................................................................15SectionIVCorporateGovernance,Environment,andSociety...........................................................................62SectionVImportantMatters...................................................................................................................................72SectionVIChangesinSharesandShareholders.................................................................................................113SectionVIIBonds-relatedInformation................................................................................................................125SectionVIIIFinancialReports..............................................................................................................................126SectionIXOtherSubmittedData.........................................................................................................................345 ContentsofReferenceFile (I)Financialaccountingstatementssignedandsealedbythelegalrepresentative,thepersoninchargeofaccounting,andtheheadoftheaccountingdepartment(accountingmanager). (II)TheoriginalsofallCompany’sdocumentspubliclydisclosedinthepressdesignatedbyCSRCduringthereportingperiodandtheoriginalsofannouncements. Definitions SectionIICompanyProfileandKeyFinancialIndicators I.Companyprofile II.Contactpersonandcontactinformation III.Otherinformation 1.Companycontactinformation WhethertheCompany'sregisteredaddress,officeaddressanditspostalcode,website,oremailaddresshavechangedduringthereportingperiod 2.Informationdisclosureandstoragelocation Hastheinformationdisclosureandstoragelocationchangedduringthereportingperiod? □ApplicableNotapplicable ThestockexchangewebsiteandmedianamesandURLswheretheCompanydisclosesitssemi-annualreports,aswellasthestoragelocationofthesemi-annualreports,remainedunchangedduringthereportingperiod.Fordetails,pleaserefertothe2024AnnualReport. 3.Otherrelevantinformation Hasanyotherrelevantinformationchangedduringthereportingperiod? □ApplicableNotapplicable IVKeyaccountingdataandfinancialindicators DoestheCompanyneedtoretroactivelyadjustorrestatetheaccountingdataofpreviousyears? □YesNo TotalsharecapitaloftheCompanyasofthetradingdaypriortodisclosure: Fullydilutedearningspersharebasedonthelatestsharecapital: V.Differencesinaccountingdataunderdomesticandforeignaccountings